Biovest International, Inc. is a pioneer the field of personalized cancer vaccines and markets its state-of-the-art hollow fiber bioreactors, as well as provides custom cell culture services, including contract manufacturing. The Company exited Chapter 11 reorganization on July 9, 2013, with new shares issued to secured and unsecured creditors. Shares of common stock, warrants and options that were outstanding prior to the effective date of Biovest’s Plan of Reorganization (July 9, 2013) have been cancelled and have ceased to trade or be recognized as an ownership interest in the Company.
For more information on the reorganized Biovest, please visit this link for latest SEC filing: http://www.sec.gov/Archives/edgar/data/704384/000121465913003910/s7121308k.htm
|There are currently no events scheduled.|
Receive E-mail Alerts|
|Sign up to receive e-mail alerts whenever Biovest International Inc. posts new information to the site. Just enter your e-mail address and click Submit.|
Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.